Statin drugs have made history for their blockbuster sales, and their use is only expected to increase when Lipitor's patent soon expires. But, for millions of people, statins simply don't do enough.
Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented challenge to the US healthcare system. In a blog post ...
Current AHA guidelines call for healthy Americans to bring LDL below 100 milligrams per deciliter (mg/dL) of blood, while those who’ve had a heart attack or stroke are encouraged to drop LDL at least ...
Nat Clin Pract Oncol. 2005;2(4):174-175. In the Consumer Use Study of OTC Mevacor [6] survey of outcomes among 3,316 consumers in a simulated OTC setting, individuals with LDL cholesterol between ...
Most statin drugs are FDA-approved for children and teens under age 18, but only if they have a genetic condition that cause extremely high levels of LDL (bad) cholesterol. Yet in 2009 ...